Antidiabetic effect of (-)-epicatechin.
D000818:Animals; D001578:Benzopyrans / Q000627:therapeutic use*; D002392:Catechin / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy*; D004356:Drug Storage; D006801:Humans; D051381:Rats; D013237:Stereoisomerism
D001578:Benzopyrans; D002392:Catechin